CD133, a widely used marker for isolating cancer stem cells [31,32], and N-cadherin, a well-known marker for epithelial-to-mesenchymal transition [33], are associated with BC aggressiveness; we previously reported quantification of their expression in the same BC cohort [34]. The gene discussed is CDH2; the disease is cancer.